The up‐regulation of miR‐497 is involved in the negative modulation of Raf1 and Erk1 protein levels, but not in Erk258 which could be a determining factor in the inhibition of the Erk pathway and therefore as intermediary of SLE progression. The gene discussed is RAF1; the disease is systemic lupus erythematosus.